In Vitro Thrombogenicity Tests of Factor IX Concentrates
- 1 August 1977
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 36 (4) , 573-583
- https://doi.org/10.1111/j.1365-2141.1977.tb00998.x
Abstract
Summary. Three different types of test were compared in characterizing the properties of thrombogenic material in factor IX concentrates. The thrombin generation time (TGt50) of Sas et al (1975), the non‐activated partial thromboplastin time (NAPTT) of Kingdon et al (1975) and the factor VIII inhibitor bypassing activity (FEIBA) of Elsinger (1975) were used. When concentrates were incubated with purified antithrombin III (At III), the NAPTT lengthened but no effect was seen with the TGt50 and FEIBA. The TGt50 showed thermal sensitivity both in the presence and absence of antithrombin III. When concentrates were treated with the serine protease inhibitor diisopropylfluorophosphate (DFP), the thrombogenicity appeared to decrease slightly in all three tests, but was not completely eliminated. Heparinagarose was found to adsorb the material(s) responsible for shortening the NAPTT and TGt50, and it also adsorbed factor IX. Gel filtration studies clearly separated the three activities into different sizes; the TGt50 activity was the largest with an apparent molecular weight of 1 × 106, FEIBA activity was intermediate with an apparent molecular weight of 1.30 × 105 and NAPTT activity was the smallest with an apparent molecular weight of 7 × 104. Our results show that the thrombogenicity measured by these three tests may be related to the presence of physically distinct materials.This publication has 14 references indexed in Scilit:
- DIC and postoperative wound bleeding under factor IX substitution therapy in a case of hemophilia B; Successful treatment with heparinThrombosis Research, 1976
- Purification and Properties of Human Factor IXaThrombosis and Haemostasis, 1976
- PROTHROMBIN-COMPLEX CONCENTRATE IN TREATMENT OF CLASSICAL HÆMOPHILIA WITH FACTOR-VIII ANTIBODYThe Lancet, 1975
- In Vitro Spontaneous Thrombin Generation in Human Factor-IX ConcentratesBritish Journal of Haematology, 1975
- Purification of antithrombin III by affinity chromatographyThrombosis Research, 1974
- Prothrombin-Complex Concentrates and ThrombosesNew England Journal of Medicine, 1974
- The Purification and Mechanism of Action of Human Antithrombin-Heparin CofactorJournal of Biological Chemistry, 1973
- Coagulant Activity of Tiger Snake (Notechis scutatus scutatus) VenomNature, 1966
- The Specific Assay of Prower-Stuart Factor and Factor VIIActa Haematologica, 1961